3.8 Review

CDK9: a signaling hub for transcriptional control

Journal

TRANSCRIPTION-AUSTIN
Volume 10, Issue 2, Pages 57-75

Publisher

TAYLOR & FRANCIS INC
DOI: 10.1080/21541264.2018.1523668

Keywords

Enhancer; CDK9; P-TEFb; 7SK; RNA polymerase II; Transcription; Pausing; Elongation; Cancer; HIV; Disease

Funding

  1. National Institute of Allergy and Infectious Diseases [R01AI114362, R33AI116222]
  2. National Science Foundation [2016220513]
  3. Welch Foundation [I-1872]

Ask authors/readers for more resources

Cyclin-dependent kinase 9 (CDK9) is critical for RNA Polymerase II (Pol II) transcription initiation, elongation, and termination in several key biological processes including development, differentiation, and cell fate responses. A broad range of diseases are characterized by CDK9 malfunction, illustrating its importance in maintaining transcriptional homeostasis in basal- and signal-regulated conditions. Here we provide a historical recount of CDK9 discovery and the current models suggesting CDK9 is a central hub necessary for proper execution of different steps in the transcription cycle. Finally, we discuss the current therapeutic strategies to treat CDK9 malfunction in several disease states.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

3.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available